Bibliography
Publications
& articles
Abstract : Over the past years, targeted therapies using tyrosine kinase inhibitors (TKI) have led to an increase in progression-free survival and response rate for a subgroup of non-small cell lung cancer (NSCLC) patients harbouring specific gene abnormalities compared with chemotherapy. However long-lasting tumor regression is rarely achieved, due to the development of resistant tumoral subclones, which requires alternative therapeutic approaches. Molecular profile at progressive disease is a challenge for making adaptive treatment decisions. The aim of this study was to monitor EGFR-mutant tumors over time based on the
quantity of mutant DNA circulating in plasma (ctDNA), comparing two different methods, Crystal™ Digital™ PCR and Massive Parallel Sequencing (MPS). In plasma circulating cell free DNA (cfDNA) of 61 advanced NSCLC patients we found an overall correlation of 78% between mutated allelic fraction measured by Crystal Digital PCR and MPS… Read More
Abstract : Digital PCR is an exciting new field for molecular analysis, allowing unprecedented precision in the quantification of nucleic acids, as well as the fine discrimination of rare molecular events in complex samples. We here present a novel technology for digital PCR, Crystal Digital PCRTM, which relies on the use of a single chip to partition samples into 2D droplet arrays, which are then subjected to thermal cycling and finally read using a three-color fluorescence scanning device. This novel technology thus allows threecolor multiplexing, which entails a different approach to data analysis. In the present publication, we
present this innovative workflow, which is both fast and user-friendly, and discuss associated data analysis issue, such as fluorescence spillover compensation and data representation. Lastly, we also present proof-of-concept of this three-color detection system, using a quadriplex assay for the detection of EGFR mutations L858R, L861Q and T790M… Read More
Scientific
communications
-
- August 2018, “Going further with 3-color Crystal Digital PCR: characterizing CNV, indels and mutation linkage” by Alexandra Martin; Application Specialist at Stilla Technologies
At the 4th qPCR & dPCR Congress USA (September 13-14 2018); Holiday Inn San Francisco-Golden Gateway; San Francisco, USA - August 2018, “Implementation of Digital PCR in a Molecular Diagnostic Laboratory: Evaluation of Minimal Residual Disease” by Dr Benjamin Tournier; Dijon University Hospital
At the Next Generation Dx Summit (August 20-24 2018); Grand Hyatt Washington; Washington DC, USA - April 2018, “Tackling the challenges to implement circulating tumour DNA analysis in breast cancer patient management” by Dr Isaac Garcia-Murillas; Institute of Cancer Research (ICR)
At the AACR Annual Meeting (April 14-18 2018); McCormick Place North/South; Chicago, USA
- August 2017, “Single Cell Analysis with the Naica System” by Laura Cavé ; Application Specialist at Stilla Technologies
At the 9th Annual Next Generation Diagnostics Summit (August 15-18th 2017); Grand Hyatt Washington; Washington DC, USA - July 2017, “Digital PCR, Possibilities & Opportunities: Single Cell Analysis with the Naica System” by Alexandra MARTIN; Application Specialist at Stilla Technologies
At the 3rd q PCR & Digital PCR Congress (25-26 of July 2017); Convention Center, Philadelphia USA
- April 2017, Crystal digital PCR for detection and quantification of circulating EGFR mutations in advanced non-small cell lung cancer
Talk of Cecile Jovelet (PostDoc Researcher at Institut Gustave Roussy, France)
At Molecular Diagnostics Europe, 12/04/2017, in Lisbon, Portugal
- August 2018, “Going further with 3-color Crystal Digital PCR: characterizing CNV, indels and mutation linkage” by Alexandra Martin; Application Specialist at Stilla Technologies
- April 2017, “Monitoring EGFR mutations in lung cancer patients using 3-color Crystal Digital PCR” by Magali Droniou; Director of Applications at Stilla Technologies
At the qPCR dPCR & NGS Congress, the 8th international Gene Quantification Event (3 – 7 of April 2017), Freising-Weihenstephan, Germany
- November 2016, Poster triplex EGFR patients IGR
- October 2016, “Monitoring EGFR mutations in lung cancer patients using 3-color Crystal Digital PCR” by Rémi Dangla; CEO at Stilla Technologies
At the 4th qPCR & Digital PCR Congress (20 – 21 of October 2016); London, UK
- July 2016, “Digital PCR: Possibilities & Opportunities: Monitoring EGFR mutations in lung cancer patients using 3-color Crystal Digital PCR” by Rémi Dangla; CEO at Stilla Technologies
At the 2nd q PCR & Digital PCR Congress (12-13 of July 2016); Philadelphia, USA